Build with Axial: https://axial22.axialvc.com/
Read more at https://axial.substack.com/
Axial partners with great founders and inventors. We invest in early-stage life sciences companies such as Appia Bio, Seranova Bio, Delix Therapeutics, Simcha Therapeutics, among others often when they are no more than an idea. We are fanatical about helping the rare inventor who is compelled to build their own enduring business. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company . We are excited to be in business with you — email us at info@axialvc.com
Who leads Dyno?
Dyno Therapeutics was founded by Eric Kelsic, Adrian Veres, Sam Sinai, George Church, and Alan Crane in 2018 to bring machine learning to AAV gene therapies. Eric, Sam, and George had done pioneering work multiplex screening AAV capsids that formed the basis of the company.
What does Dyno do?
Dyno combines machine learning with high-throughput in vivo screening to develop new AAV gene therapies. The company’s platform, CapsidMap, comprehensively maps across the AAV capsid to have different tropism, better packaging, among other features. With this platform, Dyno licenses out the AAV vectors they invent to co-develop with partners.
